Operations-driven Private Equity Life Sciences Investments
Dr Felix Dahm, MD
Co-founder & Managing Partner
Read moreOperations-driven Private Equity Life Sciences Investments
E3 Life is an operator-led Private Equity firm driving transformative value creation in European Life Sciences. We pursue focused, value-based control investments in Life Sciences that have significant growth potential.
The impact of our methodologies is evident throughout our track record of meaningful operational improvement within the companies we have led or helped lead. In each case, this has resulted in significant enhancement of the company’s growth profile and valuation.
We create sustainable enterprise value from within. We serve as a hands-on partner with company executives to unlock the potential of their operations, their products and technologies, and their team.
We invest in European Life Sciences companies with a solid foundation and meaningful unrealised potential. E3 Life utilizes our operations-centric investment experience and specialist technical expertise to maximize efficiencies, pursue growth and unlock asset value.
As Life Sciences operators, E3 Life provides our partner companies with the optimal resources, experience, expertise, and approach to successfully navigate the best path forward in pursuit of enduring value creation.
E3 Life’s investment and value creation method is simple to describe, but difficult to execute. We focus on implementing Classic PE Value Creation strategies and amplifying them with our Advanced Value Creation strategies.
The goal of the E3 Life approach is to unlock growth-driven value on top of a stronger, more expansive foundation. We seek to optimize outcomes for investors and all key stakeholders.
Expert identification, access and execution for portfolio expansion and vertical integration
Build out the base capabilities, know-how, and technical expertise within the company
Pursue high-impact innovations and product launches at reasonable cost and risk
Expand geographic footprint and market access to bring proven products to new markets
Lean organizations with strong commercial performance culture and optimized efficiency
Complementary synergies of expertise, experience & networks in European Life Sciences and Private Equity